AtenololAntihypertensive AgentsHypertensionBlood PressureDiureticsHydrochlorothiazideAdrenergic beta-AntagonistsMethyldopaSodium Chloride Symporter InhibitorsAmlodipineCalcium Channel BlockersAngiotensin-Converting Enzyme InhibitorsPropanolaminesHydralazineThiazidesDoxazosinChlorthalidoneTrichlormethiazideBlood Pressure Monitoring, AmbulatoryIndapamideNifedipineBlood Pressure DeterminationBenzothiadiazinesDrug Therapy, CombinationLisinoprilRats, Inbred SHRHeart RateAngiotensin II Type 1 Receptor BlockersEnalaprilBendroflumethiazideDihydropyridinesPropranololMetoprololCaptoprilDouble-Blind MethodTetrazolesGuanabenzAngiotensin Receptor AntagonistsClonidineHypertension, RenalLosartanPulseTreatment OutcomeAdrenergic beta-1 Receptor AntagonistsClinical Trials as TopicPatient ComplianceBenzimidazolesHypertrophy, Left VentricularRisk FactorsAdrenergic alpha-AntagonistsSystolePerindoprilReninDrug PrescriptionsTime FactorsBisoprololLabetalolMinoxidilDihydralazineDrug UtilizationNordefrinNitrendipineFollow-Up StudiesRenin-Angiotensin SystemPrazosinCardiovascular DiseasesProspective StudiesBiphenyl CompoundsRats, Inbred WKYMedication AdherencePhysician's Practice PatternsDose-Response Relationship, DrugKidney Failure, ChronicPindololHypertension, MalignantHypertension, RenovascularReserpineCeliprololHemodynamicsAcebutololRandom AllocationPregnancy Complications, CardiovascularRandomized Controlled Trials as TopicKidneyDrug CostsValineGuanfacineDrug CombinationsTriamtereneDiastoleBetaxololCohort StudiesDrug InteractionsBenzoatesRetrospective StudiesPractice Guidelines as TopicOxprenololNadololRenal Artery ObstructionProteinuria